Tokyo, Japan

Koichi Yamakoshi


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Spotlight: Koichi Yamakoshi

Introduction

Koichi Yamakoshi is an innovative inventor based in Tokyo, Japan. With a notable contribution to the field of medicinal chemistry, his work continues to impact the research community, particularly in the development of compounds that target specific biological processes.

Latest Patents

Koichi Yamakoshi holds a patent for 3-substituted-4-pyrimidone derivatives. This patent describes a pyrimidone derivative that demonstrates inhibitory activity against tau protein kinase 1. The compound is represented by a specific formula, involving various substituents including C-Calkyl groups and potentially complex aromatic or heterocyclic structures. His innovative approach could have significant implications for therapeutic applications.

Career Highlights

Throughout his career, Koichi Yamakoshi has been associated with renowned companies, contributing to advancements in pharmaceuticals. He has worked at Mitsubishi Pharma Corporation and Sanofi-Synthelabo, where he was instrumental in developing new medicinal compounds. His expertise and innovative thinking have positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Yamakoshi has collaborated with talented colleagues such as Fumiaki Uehara and Keiichi Aritomo. Through these partnerships, they have combined their insights and skills to advance their research, leading to promising developments in their respective fields.

Conclusion

Koichi Yamakoshi exemplifies the spirit of innovation through his contributions to pharmaceutical chemistry. His patent on pyrimidone derivatives highlights his commitment to discovering new treatments that may help address critical health issues. As his career progresses, his continued efforts in collaboration and invention will undoubtedly shape the future of medicinal research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…